Journal article

Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation - Impact of Ras-/Rho-prenylation


Authors listAfshordel, S; Kern, B; Clasohm, J; König, H; Priester, M; Weissenberger, J; Kögel, D; Eckert, GP

Publication year2015

Pages69-77

JournalPharmacological Research

Volume number91

ISSN1043-6618

DOI Linkhttps://doi.org/10.1016/j.phrs.2014.11.006

PublisherElsevier


Abstract
Alterations in small GTPase mediated signal transduction pathways have emerged as a central step in the molecular pathogenesis of glioblastoma (GBM), the most common malignant brain tumor in adults. Farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP) are derived from mevalonate, whose production is catalyzed by 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase. Prenylation by FPP and GGPP is required for membrane insertion and oncogenic function of Ras- and Rho-proteins, within the stimulation of the Ras-Raf-MEK-ERK pathway. A straightforward prediction from HMG-CoA reductase inhibitor studies is that statins decrease FPP and GGPP levels and diminish ERK signaling ensuring less proliferation and migration of cancer cells. Perillyl alcohol (POH), a naturally occurring monoterpene inhibits prenyltransferases and is able to inhibit cancer cell growth, but the underlying mechanism is still unclear. We here report that lovastatin (LOV) and POH impair the regulation of the mevalonate- and the Ras-Raf-MEK-ERK pathway in U87 and U343 glioblastoma cells. Both compounds affected the post-translational modification of H-Ras and Rac1. While LOV diminished the substrates of the transferase reaction that catalyze prenylation, POH inhibited the enzymes itself. Our data highlight the impact of isoprenoids for post-translational modification of small GTPases promoting proliferation, migration and invasion capabilities in glioma cells. (C) 2014 Elsevier Ltd. All rights reserved.



Citation Styles

Harvard Citation styleAfshordel, S., Kern, B., Clasohm, J., König, H., Priester, M., Weissenberger, J., et al. (2015) Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation - Impact of Ras-/Rho-prenylation, Pharmacological Research, 91, pp. 69-77. https://doi.org/10.1016/j.phrs.2014.11.006

APA Citation styleAfshordel, S., Kern, B., Clasohm, J., König, H., Priester, M., Weissenberger, J., Kögel, D., & Eckert, G. (2015). Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation - Impact of Ras-/Rho-prenylation. Pharmacological Research. 91, 69-77. https://doi.org/10.1016/j.phrs.2014.11.006


Last updated on 2025-21-05 at 16:31